THOMPSON DAVIS & CO., INC. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$13,000
-74.0%
1,534
-70.1%
0.03%
-76.5%
Q2 2018$50,000
+11.1%
5,1250.0%0.12%0.0%
Q1 2018$45,000
-29.7%
5,1250.0%0.12%
-21.7%
Q4 2017$64,0005,1250.15%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders